 |
1-(3-{4-[3,4-difluoro-2-(trifluoromethyl)phenyl]piperidine-1-carbonyl}-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-6-yl)ethan-1-one |
|---|---|
| Trade Name | |
| Orphan Indication | Stargardt Disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-09-19 00:00:00 |
| Sponsor | Lin BioScience, LLC;3210 Merryfield Row;San Diego, California, 92121 |
